Nizatidine impurities and related standards
Nizatidine is held here as a working collection of 53 reference materials across 27 CAS numbers. Within the range, the lettered series runs from C to K with 4 letters present. 29 of the entries are impurity-type materials of the parent, 6 are salt or counter-ion variants and 3 carry a deuterium label and 6 are nitrosamine analogues. 26 entries carry a verified structure drawing, a coverage of 49%; the rest are listed without a structure rather than with an unverified one. 24 of them sit in tier A or B, meaning the data behind the page is complete enough to be indexed and quoted directly, while 29 remain tier C and are kept for search coverage. The practical difficulty with a series of this size is not obtaining any one impurity but demonstrating that the set is complete. A validation package normally needs the specified impurities plus the unspecified ones above the reporting threshold, and the second group is where a catalogue either holds the material or does not. Anyone comparing two suppliers on this parent should ask the same three questions of each: which letters are held, what the content basis is, and whether the structure on the page was verified against the name rather than copied from it.
Sources: DailyMed (US NLM) - NIZATIDINE CAPSULE [EPIC PHARMA, LLC].
33 reference standards related to Nizatidine held in the RSSE catalogue — pharmacopoeial impurities, non-compendial impurities, metabolites and labelled analogues where available.
In this group: 15 impurity reference standards · 10 fine chemicals · 3 general reference standards · 2 drug metabolite standards. CAS numbers are listed for 33 of 33; 32 entries carry a structure drawing.
On this page
33 reference standards
All entries — structure, identifiers and pack sizes
-
Nizatidine
IN STOCKRS-U054328 -
Nizatidine EP Impurity A
IN STOCKRS-N078010 -
NIzatidine EP Impurity B
IN STOCKRS-N078008 -
Nizatidine EP Impurity B
CUSTOM SYNTHESISRS-Z413DZH -
Nizatidine EP Impurity E
IN STOCKRS-N078017 -
Nizatidine EP Impurity E (Sodium Salt)
CUSTOM SYNTHESISRS-N078018 -
Nizatidine EP Impurity H
IN STOCKRS-N078007 -
Nizatidine EP Impurity H (Hydrochloride Salt)
IN STOCKRS-N078006 -
Nizatidine EP Impurity I
IN STOCKRS-N078014 -
Nizatidine EP Impurity J
IN STOCKRS-N078012 -
Nizatidine EP Impurity C
IN STOCKRS-N078001 -
Nizatidine-Impurity D (Di Oxalate)
CUSTOM SYNTHESISRS-N078011 -
Nizatidine EP Impurity F
IN STOCKRS-N078002 -
Nizatidine EP Impurity G
IN STOCKRS-N078003 -
Nizatidine-Impurity J (Hydrochloride Salt)
IN STOCKRS-N078013 -
Nizatidine EP Impurity K (Free base)
IN STOCKRS-N078005 -
(2-(DIMETHYLAMINO)THIAZOL-4-YL)METHANOL
CUSTOM SYNTHESISRS-U069139 -
(EZ)-1-Methylamino-1-methylthio-2-nitroethene
IN STOCKRS-N078022 -
1,3-Dichloroacetone
IN STOCKRS-P006112 -
1,3-Thiazol-2-ylmethanol
IN STOCKRS-U016520 -
1-(4-(Chloromethyl)thiazol-2-yl)-N,N-dimethylmethanamine
CUSTOM SYNTHESISRS-U006576 -
2-(Dimethylaminomethyl)-4-(2-aminoethylthiomethyl)thiazole
IN STOCKRS-U069321 -
2-(methylamino)ethanethioamide
IN STOCKRS-U010430 -
2-Methylaminothioacetamide Hydrochloride
IN STOCKRS-I015127 -
4-(Hydroxymethyl)thiazole (BSC)
IN STOCKRS-U067848 -
Nizatidine N-Desmethyl Metabolite
IN STOCKRS-N078016 -
Nizatidine N-Oxide
IN STOCKRS-N078019 -
nizatidine sulfoxide
BACK ORDERRS-N078020 -
Nizatidine-d3
IN STOCKRS-N078004 -
tert-Butyl ((4-(((2-aminoethyl)thio)methyl)thiazol-2-yl)methyl)(methyl)carbamate
BACK ORDERRS-Z400UR9 -
tert-Butyl (2-amino-2-oxoethyl)(methyl)carbamate
IN STOCKRS-Z401MH4 -
tert-Butyl (2-amino-2-thioxoethyl)(methyl)carbamate
IN STOCKRS-P010578 -
Nizatidine Impurity 7
IN STOCKRS-N078015
33 reference standards
Frequently asked
How many Nizatidine-related reference standards do you hold?
Can you supply a Nizatidine impurity that is not listed here?
What documentation is supplied with Nizatidine impurities?
Do you publish prices or a lead time for Nizatidine impurities?
Cannot find the impurity you need? Non-compendial impurities can be quoted from a structure — a CAS number is not required. Write to sales@rssechem.com.






























